系统性硬化症中的高级自身抗体检测
Advanced Autoantibody Testing in Systemic Sclerosis.
作者信息
Almaabdi Kholoud, Ahmad Zareen, Johnson Sindhu R
机构信息
Toronto Scleroderma Program, Division of Rheumatology, Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON M5T 1R8, Canada.
Toronto Scleroderma Program, Schroeder Arthritis Institute, Division of Rheumatology, Department of Medicine, Toronto Western Hospital, Toronto, ON M5T 379, Canada.
出版信息
Diagnostics (Basel). 2023 Feb 23;13(5):851. doi: 10.3390/diagnostics13050851.
Abstract
Systemic sclerosis is a systemic autoimmune rheumatic disease characterized by immune abnormalities, leading to vasculopathy and fibrosis. Autoantibody testing has become an increasingly important part of diagnosis and prognostication. Clinicians have been limited to antinuclear antibody (ANA), antitopoisomerase I (also known as anti-Scl-70) antibody, and anticentromere antibody testing. Many clinicians now have improved access to an expanded profile of autoantibody testing. In this narrative review article, we review the epidemiology, clinical associations, and prognostic value of advanced autoantibody testing in people with systemic sclerosis.
摘要
系统性硬化症是一种系统性自身免疫性风湿性疾病，其特征为免疫异常，可导致血管病变和纤维化。自身抗体检测已成为诊断和预后评估中日益重要的一部分。临床医生以往仅限于检测抗核抗体（ANA）、抗拓扑异构酶I（也称为抗Scl-70）抗体和抗着丝粒抗体。现在，许多临床医生能够更方便地进行更广泛的自身抗体检测。在这篇叙述性综述文章中，我们回顾了系统性硬化症患者进行先进自身抗体检测的流行病学、临床关联及预后价值。
相似文献
1
Advanced Autoantibody Testing in Systemic Sclerosis.系统性硬化症中的高级自身抗体检测
Diagnostics (Basel). 2023 Feb 23;13(5):851. doi: 10.3390/diagnostics13050851.
2
[Nuclear auto-antibodies: a useful tool for the diagnosis, the classification and the prognosis of systemic sclerosis].[核自身抗体：系统性硬化症诊断、分类及预后的有用工具]
Rev Med Interne. 2004 Jun;25(6):442-7. doi: 10.1016/j.revmed.2003.11.012.
3
Clinical significance of antinuclear antibodies in Japanese patients with systemic sclerosis.抗核抗体在日本系统性硬化症患者中的临床意义。
Dermatologica. 1990;180(3):136-40. doi: 10.1159/000248013.
4
The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.日本系统性硬化症患者血清抗核抗体的临床相关性
Br J Dermatol. 2008 Mar;158(3):487-95. doi: 10.1111/j.1365-2133.2007.08392.x. Epub 2008 Jan 17.
5
Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance.系统性硬化症和纤维化综合征中的自身抗体：临床指征及相关性
Curr Opin Rheumatol. 2004 Nov;16(6):723-32. doi: 10.1097/01.bor.0000144760.37777.fa.
6
[Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].抗微管蛋白-α-1C自身抗体在系统性硬化症中的意义
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Dec 18;52(6):1009-1013. doi: 10.19723/j.issn.1671-167X.2020.06.004.
7
Antinuclear antibodies and clinical associations in a british cohort with limited cutaneous systemic sclerosis.抗核抗体与局限性皮肤型系统性硬皮病英国队列中的临床相关性。
J Rheumatol. 2011 Apr;38(4):702-5. doi: 10.3899/jrheum.100754. Epub 2011 Jan 15.
8
Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis.系统性硬化症中甲襞微血管损伤和核抗体模式的进展。
J Rheumatol. 2013 May;40(5):634-9. doi: 10.3899/jrheum.121089. Epub 2013 Mar 1.
9
Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion.系统性硬化症中的抗动粒抗体和抗拓扑异构酶I抗体：使用免疫印迹重组抗原、免疫荧光和双向免疫扩散的比较研究
Arch Dermatol Res. 1990;282(2):76-83. doi: 10.1007/BF00493462.
10
Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort.系统性硬化症的临床和自身抗体谱：来自马来西亚西部队列的基线特征
Int J Rheum Dis. 2015 May;18(4):459-65. doi: 10.1111/1756-185X.12322. Epub 2014 Feb 23.
引用本文的文献
1
Anti-Ku Antibodies: Clinical Associations, Organ Damage, and Prognostic Implications in Connective Tissue Diseases.抗Ku抗体：结缔组织病中的临床关联、器官损害及预后意义
Int J Mol Sci. 2025 Aug 1;26(15):7433. doi: 10.3390/ijms26157433.
2
A causal relationship between type 1 diabetes and risk of systemic sclerosis: a bidirectional two-sample Mendelian randomization study.1型糖尿病与系统性硬化症风险之间的因果关系：一项双向双样本孟德尔随机化研究。
Diabetol Metab Syndr. 2025 Jun 5;17(1):195. doi: 10.1186/s13098-025-01743-3.
3
A Case of Atypical Scleroderma Renal Crisis.一例非典型硬皮病肾危象病例。
Eur J Case Rep Intern Med. 2024 Jul 30;11(8):004706. doi: 10.12890/2024_004706. eCollection 2024.
4
A Multidisciplinary Approach as a Goal for the Management of Complications in Systemic Scleroderma: A Literature Review and Case Scenario.一种多学科方法作为系统性硬化症并发症管理的目标：文献综述与病例分析
Diagnostics (Basel). 2023 Oct 28;13(21):3332. doi: 10.3390/diagnostics13213332.
5
Reproducibility of pulmonary function tests in patients with systemic sclerosis.系统性硬化症患者肺功能检查的可重复性。
Sci Rep. 2023 Nov 3;13(1):18960. doi: 10.1038/s41598-023-45881-y.
6
Biomarkers in Systemic Sclerosis: An Overview.系统性硬化症中的生物标志物：概述
Curr Issues Mol Biol. 2023 Sep 25;45(10):7775-7802. doi: 10.3390/cimb45100490.
7
Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study.674例系统性硬化症患者肝功能检查异常的发生率及预测因素：一项队列研究
Open Access Rheumatol. 2023 May 16;15:81-92. doi: 10.2147/OARRR.S410165. eCollection 2023.
本文引用的文献
1
Altered Balance of Pro-Inflammatory Immune Cells to T Regulatory Cells Differentiates Symptomatic From Asymptomatic Individuals With Anti-Nuclear Antibodies.炎症免疫细胞与调节性 T 细胞之间平衡的改变将抗核抗体阳性的有症状个体与无症状个体区分开来。
Front Immunol. 2022 Jun 30;13:886442. doi: 10.3389/fimmu.2022.886442. eCollection 2022.
2
Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.硬皮病标志性自身抗体的组合与不同的临床表型相关。
Sci Rep. 2022 Jul 2;12(1):11212. doi: 10.1038/s41598-022-15062-4.
3
Signal Recognition Particle in Human Diseases.人类疾病中的信号识别颗粒
Front Genet. 2022 Jun 8;13:898083. doi: 10.3389/fgene.2022.898083. eCollection 2022.
4
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.系统性硬化症特异性抗体：新型和经典生物标志物。
Clin Rev Allergy Immunol. 2023 Jun;64(3):412-430. doi: 10.1007/s12016-022-08946-w. Epub 2022 Jun 18.
5
Development of Pulmonary Hypertension in Over One-Third of Patients With Th/To Antibody-Positive Scleroderma in Long-Term Follow-Up.三分之一以上抗拓扑异构酶Ⅰ抗体阳性的硬皮病患者在长期随访中出现肺动脉高压。
Arthritis Rheumatol. 2022 Sep;74(9):1580-1587. doi: 10.1002/art.42152. Epub 2022 Jul 21.
6
The International Consensus on ANA Patterns (ICAP) in 2021-The 6th Workshop and Current Perspectives.2021 年国际抗核抗体模式共识（ICAP）——第六届研讨会和当前观点。
J Appl Lab Med. 2022 Jan 5;7(1):322-330. doi: 10.1093/jalm/jfab140.
7
Anti-Ro/SS-A antibody is associated with worse pulmonary outcome and reduced overall survival in systemic sclerosis.抗 Ro/SS-A 抗体与系统性硬化症患者的肺预后不良和总生存降低相关。
Mod Rheumatol. 2022 Oct 15;32(6):1086-1093. doi: 10.1093/mr/roab118.
8
Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates.血清器官特异性抗心脏和抗闰盘自身抗体作为系统性硬化症心脏受累的新型自身免疫标志物：频率、临床及预后相关性
Diagnostics (Basel). 2021 Nov 22;11(11):2165. doi: 10.3390/diagnostics11112165.
9
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients.高分辨率计算机断层扫描：改善系统性硬化症相关间质性肺病患者护理中的利弊
Diagnostics (Basel). 2021 Oct 22;11(11):1960. doi: 10.3390/diagnostics11111960.
10
Clinical significance of anti-NOR90 antibodies in systemic sclerosis and idiopathic interstitial pneumonia.抗 NOR90 抗体在系统性硬化症和特发性间质性肺炎中的临床意义。
Rheumatology (Oxford). 2022 Apr 11;61(4):1709-1716. doi: 10.1093/rheumatology/keab575.
Zotero 插件